Genetic Diversity of the KIR/HLA System and Outcome of Patients with Metastatic Colorectal Cancer Treated with Chemotherapy

• Valli De Re ,

  * E-mail: vdere@cro.it

  Affiliation Translational Research, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy

  ⨯
• Laura Caggiari,

  Affiliation Translational Research, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy

  ⨯
• Mariangela De Zorzi,

  Affiliation Translational Research, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy

  ⨯
• Renato Talamini,

  Affiliation Epidemiology and Biostatistics, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy

  ⨯
• Vito Racanelli,

  Affiliation Internal Medicine and Clinical Oncology, University of Bari Medical School, Bari, Italy

  ⨯
• Mario D’ Andrea,

  Affiliation Medical Oncology Unit, San Filippo Neri Hospital, Rome, Italy

  ⨯
• Angela Buonadonna,

  Affiliation Medical Oncology, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy

  ⨯
• Vittorina Zagonel,

  Affiliation Medical Oncology, Istituto Oncologico Veneto, IRCCS, Padova, Italy

  ⨯
• Erika Cecchin,

  Affiliation Translational Research, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy

  ⨯
• Federico Innocenti,

  Affiliation University of North Carolina, Institute for Pharmacogenomics and Individualized Therapy, Eshelman School of Pharmacy, School of Medicine, Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina, United States of America

  ⨯
• Giuseppe Toffoli

  Affiliation Translational Research, CRO National Cancer Institute, IRCCS, Aviano, Pordenone, Italy

  ⨯